Choose a Topic
News
View the latest transplant news and stories.
Results of Pre-MEASURE Study By NMDP/Be The Match, CIBMTR, and the NHLBI Published in JAMA
March 2023
The Pre-MEASURE study was a multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.
Jeffery J. Auletta, MD, will Co-Chair the ASTCT Working Group with Stella M. Davies, MBBS, PhD, MRCP, Immediate Past President, ASTCT, Director, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital.
The ONE Forum 2022 gives industry professionals practical strategies and best practices to break down barriers from diagnosis through treatment and recovery and expand access to treatment for more patients.
The AcCELLerate Forum To Focus On Creating A Sustainable Ecosystem of Cell and Gene Therapy
October 2022
Virtual workshop on November 17 and 18 bridges the gap between critical stakeholders to pinpoint today’s challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.
National Marrow Donor Program/Be The Match Awards Amy Strelzer Manasevit Research Program Grant to Dan Peltier, MD, PhD
February 2022
National Marrow Donor Program®/Be The Match® Awards Amy Strelzer Manasevit Research Program Grant to Dan Peltier, MD, PhD. The grant provides $400,000 over five years of research to improve post-transplant health outcomes.
Approach for mismatched, unrelated bone marrow donors could expand transplant options for racially/ethnically diverse patients
The TRANSPLANT Act would reauthorize the C.W. Bill Young Cell Transplantation Program, which provides lifesaving bone marrow and umbilical cord blood transplants to patients in need
National Marrow Donor Program/Be The Match Announce Plan to Launch ACCESS Clinical Trial
February 2021
Assessing HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplantation cyclophosphamide
BMT CTN research presented today at the 62nd ASH Annual Meeting & Exposition MINNEAPOLIS, MINN.—DEC. 5, 2020— Initial results from a recent study indicate that for patients between the ages of 50 and 75, overall survival nearly doubled when patients with myelodysplastic syndrome (MDS) re
NMDP/Be The Match announces the launch of Be The Match BioBank cryopreservation service
November 2020
Service helps increase donor availability and add reliability to a patient’s transplant timeline
Program offers more convenience for blood stem cell donors, more reliability for patients and physicians
The National Marrow Donor Program ® (NMDP)/Be The Match ® today announced the appointment of Amy Ronneberg as Chief Executive Officer (CEO)—the first female CEO for the organization.
MN Medicaid patients now have access to potentially life-saving clinical trials.